Concordia Healthcare to buy some assets of Covis Pharma for $1.2 billion-Reuters

Concordia Healthcare Corp (CXR.TO), which makes drugs for rare diseases and devices for diabetic patients, said it would buy some assets of privately held Covis Pharma Holdings SARL for $1.2 billion in cash.

DealsNorth AmericaUSBriefs